LATE ABSTRACT SUBMISSION OPEN

Good news! Late abstract submission is now open. You have until July to prepare and submit your research, and have the chance to be published in The Human Gene Therapy Journal. Join the pioneers in the field of immunotherapy in Madrid this September. Your research is shaping the future!

Deadline for submission: 10 July 2018

 

I WANT TO GET FEATURED

 

WHAT IS THE NEXT STEP TO ADVANCE IMMUNOTHERAPY?

Andrew Scharenberg.jpg At ICLE 2018, Prof. Andrew Scharenberg, CSO of Casebia , USA, will be speaking on “Engineering regulatory T cell therapeutics”, as part of a session on New Horizons for Lymphocyte and HSC Engineering.

Here is what he shared with us on the future of lymphocyte engineering:

"I’m not sure that there is a single next in order to advance immunotherapy - rather - I see the field advancing more like cell phone technology, with gradual incremental progress across a number of areas, ranging from specific engineered features to development of sensitive and specific assays to assess performance properties of the starting and final cell populations."

READ THE WHOLE INTERVIEW


 

GET YOUR ABSTRACT PUBLISHED

SPONSOR-EXHIBIT MEET THE SPEAKERS
 

ICLE 2018 is chaired by Adi Barzel, President of the Israeli Society of Gene and Cell Therapy.
Advisory Board: Malcolm Brenner, Paula Cannon, Cyrille Cohen, Zelig Eshhar, Dinorah Friedmann-Morvinski, Stephen Gottschalk, Gideon Gross, Ayal Hendel, Carl June, Bruce Levine, Marcela Maus, Dan Peer, Mattew Porteus, Daniel Powell, Barbara Savoldo.

 

ORIGINAL EVENT
Rue François-Versonnex 7, 1207 Geneva, Switzerland
www.kenes.com | info@kenes.com
© Kenes Group 2018 | All Rights Reserved.
Contact Us | Unsubscribe